Digital Health Literacy on COVID-19 for All: Co-creation and Evaluation of Interventions for Ethnic Minorities and Chinese People With Chronic Illnesses in Hong Kong
1 other identifier
interventional
528
0 countries
N/A
Brief Summary
During the pandemic, people are anxious for information, and electronic platform serves the purpose of having first-hand health information and spreading it to massive population within a short time. However, the source and credibility of the influx of online information are hard to be verified. Digital health literacy (DHL) is the capacity to access, understand, evaluate, and apply health information from electronic sources, which is an important attribute that everyone should possess. Recent studies from our group in Hong Kong have shown that, during the COVID-19 pandemic, DHL is an issue facing people of all ages, especially ethnic minorities (EMs), people with chronic illnesses (PWCI), and professional and lay caregivers (CGs). Considering that, the present research project aims to co-create DHL interventions with these three groups of people to meet their specific needs in DHL, in addition, to assess the efficacy of the DHL interventions on eHealth literacy, vaccine literacy, and actions taken for COVID-19 prevention. The present research is a 4-year project, involving three phases. Phase 1 involves focus group interviews and cognitive interviews with the three groups of people for developing interventions and evaluating the proposed interventions. Phase 2 involves individual interviews with the three groups of people for testing the feasibility and acceptability of the interventions. Phase 3 involves a 6-month longitudinal quantitative research, testing for the efficacy of the interventions in three dimensions: literacy, attitude, and behavior. Participants from the three groups will be invited to join virtual or face-to-face training, watch short videos on social media, participate in virtual bi-weekly group discussion, and fill in questionnaires for five times during the course of the study. This co-creation of new knowledge by stakeholders and researchers is expected to increase the uptake of the research outcomes and adoption of the DHL interventions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2023
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 21, 2023
CompletedFirst Posted
Study publicly available on registry
August 22, 2023
CompletedStudy Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedAugust 22, 2023
August 1, 2023
1.3 years
August 21, 2023
August 21, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
eHealth Literacy Efficacy
Measured by the eHealth Literacy scale (eHEAL), an 8-item self-reported efficacy scale scored on a 5-point Likert scale
baseline, 8-week post intervention, 4-week post follow-up, 8-week follow up, and 12 week follow up
Secondary Outcomes (3)
Digital Health Literacy
baseline, 8-week post intervention, 4-week post follow-up, 8-week follow up, and 12 week follow up
Vaccine literacy
baseline, 8-week post intervention, 4-week post follow-up, 8-week follow up, and 12 week follow up
Knowledge, attitudes, and practices towards COVID-19
baseline, 8-week post intervention, 4-week post follow-up, 8-week follow up, and 12 week follow up
Study Arms (2)
Digital health literacy intervention
EXPERIMENTALThe interventions will be developed based on the Best Practices for Digital Health Literacy, WHO health literacy toolkits and the findings of the interviews. The content to be covered in the intervention will include news about vaccines; alerts about COVID-19 preventive measures; guidelines on social distancing, COVID-19 screening test arrangements, vaccination and compulsory quarantines; COVID-19-related law enforcement; and self-monitoring of COVID-19 symptoms
Control
NO INTERVENTIONNo intervention will be provided to the control group
Interventions
Participants from the intervention group will be invited to join virtual or face-to-face training, watch short videos on social media, participate in virtual bi-weekly group discussion, and fill in questionnaires for five times during the course of the study
Eligibility Criteria
You may qualify if:
- ethnic minorities (EMs), people with chronic illnesses (PWCI), and caregivers (CGs)
- able to use a computer, smartphone, or laptop to access the Internet at home
You may not qualify if:
- diagnosis of an acute psychotic disease or life-limiting condition; having a visual, auditory, or fine motor disorder.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- This is a single-blinded, randomized controlled trial that outcome assessors will be prevented from having knowledge of the interventions assigned to individual participant
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 21, 2023
First Posted
August 22, 2023
Study Start
September 1, 2023
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
August 22, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share
Data can be obtained from principal investigator.